Stockscreener 앱 받기
1.58
1.25%
-0.02
시간 외 거래:
1.58
전일 마감가:
$1.60
열려 있는:
$1.58
하루 거래량:
69,044
Relative Volume:
0.61
시가총액:
$62.50M
수익:
$63.15M
순이익/손실:
$-40.30M
주가수익비율:
-0.9461
EPS:
-1.67
순현금흐름:
$-44.47M
1주 성능:
-8.14%
1개월 성능:
-21.39%
6개월 성능:
-39.46%
1년 성능:
-48.53%
1일 변동 폭
$1.55
$1.6381
1주일 범위
$1.40
$2.1399
52주 변동 폭
$0.8645
$3.26
Tela Bio Inc Stock (TELA) Company Profile
명칭
Tela Bio Inc
전화
484-320-2930
주소
1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, PA
TELA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TELA
Tela Bio Inc
|
1.58 | 63.39M | 63.15M | -40.30M | -44.47M | -1.67 |
|
ABT
Abbott Laboratories
|
131.75 | 225.01B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.17 | 154.32B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
381.91 | 144.71B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
93.02 | 117.85B | 33.54B | 4.69B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.26 | 45.90B | 5.69B | 1.41B | 577.90M | 6.95 |
Tela Bio Inc Stock (TELA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-21 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-05-31 | 개시 | Lake Street | Buy |
| 2019-12-03 | 개시 | Canaccord Genuity | Buy |
| 2019-12-03 | 개시 | JMP Securities | Mkt Outperform |
| 2019-12-03 | 개시 | Jefferies | Buy |
| 2019-12-03 | 개시 | Piper Jaffray | Overweight |
모두보기
Tela Bio Inc 주식(TELA)의 최신 뉴스
Leading vs lagging indicators on TELA Bio Inc. performance2025 Trade Ideas & Reliable Intraday Trade Alerts - Newser
How TELA Bio Inc. stock performs during market volatilityQuarterly Portfolio Summary & Technical Entry and Exit Alerts - thegnnews.com
How to use Fibonacci retracement on TELA Bio Inc.2025 EndofYear Setup & Free High Return Stock Watch Alerts - Newser
Is TELA Bio Inc. forming a bottoming baseJuly 2025 PreEarnings & Capital Efficient Trade Techniques - Newser
Can trapped investors hope for a rebound in TELA Bio Inc.Quarterly Portfolio Review & Reliable Volume Spike Trade Alerts - Newser
Using flow based indicators on TELA Bio Inc.Portfolio Return Report & Growth-Oriented Investment Plans - Newser
Can swing trading help recover from TELA Bio Inc. lossesCPI Data & Stock Portfolio Risk Management - Newser
TELA Bio Inc. stock trend forecastJuly 2025 Earnings & Capital Efficiency Focused Ideas - Newser
TELA Bio Posts Double-Digit Revenue Growth, Expands Product Reach in Q2 - msn.com
TELA Bio Awards Inducement Equity Grants to New Employees - msn.com
TELA Bio’s SWOT analysis: biologic innovator’s stock faces growth hurdles - Investing.com India
Investors Give TELA Bio, Inc. (NASDAQ:TELA) Shares A 27% Hiding - 富途牛牛
Insider Traders Lose US$143k As TELA Bio Drops - simplywall.st
Tools to assess TELA Bio Inc.’s risk profileJuly 2025 Update & Verified Momentum Watchlists - Newser
TELA Bio’s SWOT analysis: biologic innovator’s stock faces growth hurdles By Investing.com - Investing.com South Africa
TELA Bio, Inc. (TELA) Reports Q2 Loss, Lags Revenue Estimates - MSN
Tela Bio at Canaccord Conference: Strategic Growth in Soft Tissue Repair - Investing.com Canada
Tela Bio shares fall 2.50% premarket after announcing inducement grants to new employees. - AInvest
Tela Bio reiterates $85M–$88M 2025 revenue target as international expansion accelerates - MSN
Will TELA Bio Inc. stock benefit from AI tech trendsSwing Entry Risk Mitigation with Chart Analysis - Newser
Tela Bio shares fall 6.88% after-hours following inducement grants to new employees. - AInvest
TELA Bio (TELA) Gets a Buy from Lake Street - The Globe and Mail
TELA Bio 2025 Q2 Earnings Net Loss Narrows Amid Revenue Growth - AInvest
TELA Bio Reports Strong Q2 2025 Financial Results - msn.com
TELA Bio Inc (TELA) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ... - Yahoo Finance
TELA Bio Inc (TELA) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ... By GuruFocus - Investing.com Canada
TELA Bio Reports Strong Q2 2025 Growth - TipRanks
TELA Bio Reports Second Quarter 2025 Financial Results - GlobeNewswire
TR | OpenAI4o Maintains TELA Bio(TELA.US) With Hold Rating, Maintains Target Price $2 - 富途牛牛
TELA Bio’s Revenue Climbed But Fell Short Of Expectations - Finimize
Contradictions Unveiled: TELA Bio's Q2 2025 Earnings Call Highlights Shifts in Sales Strategy, Product Growth, and Pricing Positioning - AInvest
Tela Bio (TELA): A Compelling Post-Earnings Case for Long-Term Value Creation in a High-Growth MedTech Sector - AInvest
Tela Bio's 2025 Revenue Guidance and Global Expansion: A Strategic Inflection Point for Scalable Growth - AInvest
Tela Bio Exceeds $20M Revenue in Q2 2025, Reiterates $85M-$88M 2025 Target Amid International Expansion - AInvest
Earnings call transcript: Tela Bio Q2 2025 sees stock rise despite EPS miss - Investing.com Canada
Tela Bio earnings missed by $0.04, revenue fell short of estimates - Investing.com Canada
Intraday pattern recognizer results for TELA Bio Inc.Daily Stock Watch Summary with Key Insights - Newser
TELA Bio's Q2 Revenue Miss: A Crossroads of Short-Term Pressures and Long-Term R&D Promise in Biotech - AInvest
TELA Bio misses Q2 revenue estimates - MarketScreener
What machine learning models say about TELA Bio Inc.Predicted Market Direction Based on Momentum - Newser
How to use a screener to detect TELA Bio Inc. breakoutsHigh Probability Trade Outcome Prediction - Newser
Tela Bio Inc (TELA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.74%
0.24%
자본화:
|
볼륨(24시간):